Page last updated: 2024-10-20

pyrazinamide and Escherichia coli Infections

pyrazinamide has been researched along with Escherichia coli Infections in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.

Research Excerpts

ExcerptRelevanceReference
"No other case of spondylodiscitis caused by a mycobacterial coinfection pathogen has been reported so far."1.33[Cervical spondylodiscitis: one pathogen may hide another]. ( Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toubiana, J1
Salomon, J1
Ader, F1
Perronne, C1
Carlier, R1
Bernard, L1

Other Studies

1 other study available for pyrazinamide and Escherichia coli Infections

ArticleYear
[Cervical spondylodiscitis: one pathogen may hide another].
    Medecine et maladies infectieuses, 2006, Volume: 36, Issue:1

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Disc

2006